Meet with the KBI Biopharma Team:
Integrated Development Solutions: Access expertise across cell line development, analytical development, formulation, process development, and cGMP manufacturing. KBI connects capabilities across the development lifecycle to help reduce handoffs and keep your program moving.
Advanced Cell Line Development: Explore KBI’s CLD technologies, including SUREmAb™, TranspoEase™ Select, and SUREpool™, designed to accelerate candidate evaluation, improve expression, and generate representative material earlier for development studies.
Mammalian and Microbial Expertise: Find the right development path for your molecule with mammalian and microbial capabilities, including PUREplatform™, designed to support efficient protein expression and scalable manufacturing.
Flexible Standalone Services: Need targeted expertise without a fully integrated program? Access specialized analytical, formulation, and development capabilities through KBI’s standalone services portal for flexible support when and where you need it.
Stop by the KBI booth to meet our experts, explore our development and manufacturing capabilities, and discuss your program, or book a one-on-one meeting with our team.
About KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
BIO-Europe brings together biotechnology companies, pharmaceutical organizations, investors, and development and manufacturing partners to advance innovation, investment, and strategic collaboration. Through targeted partnering meetings, thought leadership sessions, and networking opportunities, participants can explore complementary expertise, discuss program priorities, and build relationships that support biologics development from early planning through clinical and commercial manufacturing, with the shared goal of advancing promising therapies to patients.